Jiesi Lin (杰思林)杰思林
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 赛诺菲 (杭州)制药有限公司Chinese legal name: 赛诺菲 (杭州制药有限公司)
主要成分Active Ingredients
- 每粒含吡拉西坦Recorded Chinese composition: 每粒含吡拉西坦
- 重酒石酸胆碱Zhongjiu Shisuan Danjian
药物知识说明
每粒含吡拉西坦是一种在国家药监局注册认定的药品。该药品含有重酒石酸胆碱-71b6c729等成分。
该药品关联的活性成分包括：重酒石酸胆碱Zhongjiu Shisuan Danjian。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：赛诺菲 (杭州)制药有限公司Chinese legal name: 赛诺菲 (杭州制药有限公司)。
您可以探索含有相同成分的其他药品：重酒石酸胆碱-71b6c729成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 杰思林) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 重酒石酸胆碱Zhongjiu Shisuan Danjian.
Manufacturers recorded for this product: 赛诺菲 (杭州)制药有限公司Chinese legal name: 赛诺菲 (杭州制药有限公司).
Explore other medicines containing the same ingredient: 重酒石酸胆碱 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 杰思林Recorded Chinese name: 杰思林
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 吡拉西坦0.114g，重酒石酸胆碱0.2Recorded Chinese description: 吡拉西坦0.114g，重酒石酸胆碱0.2
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 赛诺菲 (杭州)制药有限公司Chinese legal name: 赛诺菲 (杭州制药有限公司)
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10950257
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10950257
Manufacturer
Chinese legal name: 赛诺菲 (杭州)制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10950257
生产企业
赛诺菲 (杭州)制药有限公司(国产)
适应症
用于改善中老年单纯性记忆减退。
用法用量
口服。一次2粒，一日3次，饭后服，疗程2个月，或遵医嘱。
不良反应
表现为口干，上腹部不适，食欲减退，腹泻，头昏，头痛，轻度兴奋，失眠，视力模糊，鼻塞，停药后可自行消失。
禁忌
尚不明确。
注意事项
1．重度肾功能不全者，消化道溃疡者慎用。2．不宜与拟胆碱药合用。3．本品应在医生指导下使用。
贮藏
干燥，阴凉处密封保存。
规格
吡拉西坦0.114g，重酒石酸胆碱0.2
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.